98 related articles for article (PubMed ID: 8556924)
21. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.
Nielen MM; van der Horst AR; van Schaardenburg D; van der Horst-Bruinsma IE; van de Stadt RJ; Aarden L; Dijkmans BA; Hamann D
Ann Rheum Dis; 2005 Aug; 64(8):1199-204. PubMed ID: 15640269
[TBL] [Abstract][Full Text] [Related]
22. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
23. Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis.
Masdottir B; Jónsson T; Manfredsdottir V; Víkingsson A; Brekkan A; Valdimarsson H
Rheumatology (Oxford); 2000 Nov; 39(11):1202-5. PubMed ID: 11085797
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study.
van Zeben D; Hazes JM; Zwinderman AH; Cats A; van der Voort EA; Breedveld FC
Ann Rheum Dis; 1992 Sep; 51(9):1029-35. PubMed ID: 1417131
[TBL] [Abstract][Full Text] [Related]
25. Role of IgM & IgA rheumatoid factors in complement activation in patients with juvenile rheumatoid arthritis.
Bhardwaj A; Aggarwal A; Agarwal V; Misra R
Indian J Med Res; 2000 Mar; 111():103-9. PubMed ID: 10937386
[TBL] [Abstract][Full Text] [Related]
26. Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients.
García-Berrocal B; González C; Pérez M; Navajo JA; Moreta I; Dávila C; González-Buitrago JM
Clin Chim Acta; 2005 Apr; 354(1-2):123-30. PubMed ID: 15748608
[TBL] [Abstract][Full Text] [Related]
27. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
[TBL] [Abstract][Full Text] [Related]
28. [Rheumatoid factors of immunoglobulin classes IgA, IgG and IgM: methods of determination and clinical value].
Hermann E; Vogt P; Müller W
Schweiz Med Wochenschr; 1986 Sep; 116(38):1290-7. PubMed ID: 3775335
[TBL] [Abstract][Full Text] [Related]
29. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
30. [Clinico-diagnostic significance of rheumatoid factors of different classes in rheumatoid arthritis].
Zborovskiĭ AB; Lempert BA; Guglina ME
Sov Med; 1989; (12):6-9. PubMed ID: 2698511
[TBL] [Abstract][Full Text] [Related]
31. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
32. Dot-blot ELISA for the detection of IgM RF and IgA RF.
Banchuin N; Janyapoon K; Parivisutt L; Sarntivijai S
Asian Pac J Allergy Immunol; 1992 Jun; 10(1):39-45. PubMed ID: 1418182
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis.
Paimela L; Palosuo T; Leirisalo-Repo M; Helve T; Aho K
Br J Rheumatol; 1995 Dec; 34(12):1146-50. PubMed ID: 8608356
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis.
Houssien DA; Jonsson T; Davies E; Scott DL
J Rheumatol; 1997 Nov; 24(11):2119-22. PubMed ID: 9375869
[TBL] [Abstract][Full Text] [Related]
35. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
[TBL] [Abstract][Full Text] [Related]
36. Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study.
Mjaavatten MD; van der Heijde DM; Uhlig T; Haugen AJ; Nygaard H; Bjørneboe O; Kvien TK
J Rheumatol; 2011 Nov; 38(11):2336-41. PubMed ID: 21965645
[TBL] [Abstract][Full Text] [Related]
37. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
Nikolaisen C; Rekvig OP; Nossent HC
Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of rheumatoid test procedures--value and critical interpretation of sensitivity and specificity and their effect on pre-test and post-test probability].
Aupperle KR; Alsalameh S; Stock KP; Burmester GR; Kalden JR
Z Rheumatol; 1996; 55(3):158-67. PubMed ID: 8768145
[TBL] [Abstract][Full Text] [Related]
39. [IgA rheumatoid factor and prognosis in chronic polyarthritis].
Wagner E; Hofmann E; Feyertag J; Dunky A
Wien Med Wochenschr; 1999; 149(19-20):548-9. PubMed ID: 10637964
[TBL] [Abstract][Full Text] [Related]
40. [Clinical significance of IgG rheumatoid factor in patients with rheumatoid arthritis].
Naka T; Kondo M; Mashima T
Ryumachi; 1995 Jun; 35(3):530-7. PubMed ID: 7570206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
